Compare
Up to four compounds, side by side.
Search or pick a starting set. Differences light up so you can spot them fast.
Amycretin
1 / 4
Peptide
GLP-1 / Amylin Co-Agonist
AmycretinOverview
Summary
Novo single-molecule GLP-1 plus amylin agonist with striking early loss.
Category
GLP-1 / Amylin Co-Agonist
Mechanism
Novo single-molecule GLP-1 plus amylin agonist with striking early loss.
Effects
Top outcomes
- Fat loss70
Evidence
Emerging
Practical
Half-life
Long (days+)
Administration
subqoral
Risk
Legal status
research only
Safety
Educational reference only. Long-term human safety varies; consult a peptide-literate clinician.
Try a preset